SRRK Scholar Rock Holding Corp

8-K Current Report

Filed: March 3, 2026

Health Care

Biological Products, (No Diagnostic Substances)

Scholar Rock Holding Corp (SRRK) 8-K current report filed with SEC EDGAR on March 3, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
2 items

Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

• Full-year 2025 earnings release issued March 3, 2026 — details in Exhibit 99.1
• Key financials (revenue, net loss, cash runway) available in the press release, critical for a clinical-stage biotech tracking burn rate

Item 7.01 · Regulation FD Disclosure

• Conference call scheduled March 3, 2026 at 8:15am ET to present full-year 2025 financial and operating results
• Slides (Exhibit 99.1) will accompany the call — key venue for pipeline/commercial updates investors should monitor

+1 more insights

Other Scholar Rock Holding Corp 8-K Filings

8-K Mar 3, 2026

Get deeper insights on Scholar Rock Holding Corp

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.